Plasma fibrinogen levels are associated with a strong family history of myocardial infarction

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 6, 2004, Pages 497-502

  Robinson, Daniel M ^a   Schwahn, Christian ^a   Alte, Dietrich ^a   John, Ulrich ^a   Felix, Stephan B ^a   Völzke, Henry ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Coronary artery disease; Family history of myocardial infarction; Fibrinogen

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FAMILY HISTORY; FEMALE; FIBRINOGEN BLOOD LEVEL; GERMANY; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; COMORBIDITY; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOGEN; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARENTS; RISK FACTORS; SAMPLING STUDIES; SIBLINGS;

EID: 4444239065     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200408000-00009     Document Type: Article

References (37)

1. Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican-Americans: the San Antonio Heart Study. Am J Epidemiol 1996; 144:1058-1065.
2. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Hemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 6:533-537.
3. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk for cardiovascular disease. JAMA 1987; 2581183-1186.
4. Phillips RL, Lilienfeld AM, Diamond EL, Kagan A. Frequency of coronary heart disease and cerebrovascular accidents in parents and sons of coronary heart disease index cases and controls. Am J Epidemiol 1974; 100;87-100.
5. Friedlander Y, Siscovick DS, Weinmann S, Austin MA, Psaty BM, Lemaitre RN, et al. Family history as a risk factor for primary cardiac arrest. Circulation 1998; 97:155-160.
6. Myers RH, Kiely DK, Cupples LA, Kannel WB. Parental history is an independent risk factor for coronary artery disease. The Framingham Study. Am J Heart 1990; 120:963-969.
7. Barrett-Connor E, Khaw K. Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation 1984; 69:1065-1069.
8. Colditz GA, Stampfer MJ, Willett WC, Rosner B, Speizer FE, Hennekens CH. A prospective study of parental history of myocardial infarction and coronary heart disease in women. Am J Epidemiol 1986; 123:48-58.
9. Shea S, Ottman R, Gabrieli C, Stein Z, Nichols A. Family history as an independent risk factor for coronary artery disease. J Am Coll Cardiol 1984; 4:793-801.
10. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, Ash KO. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol 1988; 62: 703-707.
11. Roncaglioni MC, Santoro L, D'Avanzo B, Negri E, Nobili A, Ledda A, et al. Role of family history in patients with myocardial infarction: an Italian case-control study: GISSI-EFRIM investigators. Circulation 1992; 85:2065-2072.
12. Green D, Ruth KJ, Folsom AR, Liu K. Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arterioscler Thromb 1994; 14:686-693.
13. Barasch E, Benderly M, Graff E, Behar S, Reicher-Reiss H, Caspi A, et al. Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients: the Bezafibrate Infarction Prevention (BIP) study. J Clin Epidemiol 1995; 48:757-765.
14. Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993; 69:338-342.
15. Friedlander Y, Arbogast P, Schwartz SM, Marcovina SM, Austin MA, Rosendaal FR, et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis 2001; 156: 201-207.
16. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347:1916-1923.
17. Croft SA, Samani NJ, Teare MD, Hampton KK, Steeds RP, Channer KS, Daly ME. Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction. Circulation 2001; 104:1459-1463.
18. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994; 89:1333-1445.
19. Sesso HD, Lee IM, Gaziano JM, Rexrode KM, Glynn RJ, Buring JE. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 2001; 104:393-398.
20. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, et al. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz-Präventivmed 2001; 46: 186-194.
21. Rose G. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Org 1962; 27:645-658.
22. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17:237-246.
23. Margaglione M, Cappucci G, Colaizzo D, Vecchione G, Grandone E, Di Minno G. C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. Arterioscler Thromb Vasc Biol 2000; 20:198-203.
24. Margaglione M, Colaizzo D, Cappucci G, del Popolo A, Vecchione G, Grandone E, Di Minno G. Genetic polymorphism of 5, 10-MTHFR reductase gene in offspring of patients with myocardial infarction. Thromb Haemost 1999; 82:19-23.
25. Shea S, Isasi CR, Couch S, Starc TJ, Tracy RP, Deckelbaum R, et al. Relations of plasma fibrinogen level in children to measures of obesity, the (G-455 →9 A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: the Columbia University BioMarkers Study. Am J Epidemiol 1999; 150:737-746.
26. Pitsavos C, Skoumas J, Dernellis J, Toutouza M, Doulalas A, Stefanadis C, Toutouzas P. Influence of biological factors on lipid and fibrinogen measurements in young men: an epidemiological study in 2009 recruits. Eur Heart J 1998; 19:1642-1647.
27. Engstrom G, Stavenow L, Hedblad B, Lind P, Tyden P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins and incidence of myocardial infarction in men with low cardiovascular risk. Arterioscler Thromb Vasc Biol 2003; 23:2247-2251.
28. Lowe GD, Woodward M, Rumley A, Morrison CE, Nieuwenhuizen W. Associations of plasma fibrinogen assays, C-reactive protein and interleukin-6 with previous myocardial infarction. J Thromb Haemost 2003; 1:2312-2316.
29. Makris TK, Hatzizacharias AN, Krespi PG, Chronakis EV, Vythoulkas JS, Maria K, et al. Markers of risk in young offspring with paternal history of myocardial infarction. Int J Cardiol 2003; 89:287-293.
30. Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation 2000; 102:1634-1638.
31. Nascetti S, Elosua R, Pena A, Covas MI, Senti M, Marrugat J. REGICOR Investigators. Variables associated with fibrinogen in a population-based study: interaction between smoking and age on fibrinogen concentration. Eur J Epidemiol 2001; 17:953-958.
32. Church TS, Finley CE, Earnest CP, Kampert JB, Gibbons LW, Blair SN. Relative associations of fitness and fatness to fibrinogen, white blood cell count, uric acid and metabolic syndrome. Int J Obs Relat Metab Disord 2002; 26:805-813.
33. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med 2000; 343: 1148-1155.
34. de Maat MP. Effects of diet, drugs, and genes on plasma fibrinogen levels. Ann NY Acad Sci 2001; 936:509-521.
35. Gardemann A, Schwartz O, Haberbosch W, Katz N, Weiss T, Tillmanns H, et al. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction. Thromb Haemost 1997; 77:1120-1126.
36. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology 2001; 40:640-646.
37. Kee F, Tiret L, Robo JY, Nicaud V, McCrum E, Evans A, Cambien F. Reliabilty of reported family history of myocardial infarction. BMJ 1993; 307:1528-1530.